258 related articles for article (PubMed ID: 23277330)
1. γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia.
Scheper W; van Dorp S; Kersting S; Pietersma F; Lindemans C; Hol S; Heijhuurs S; Sebestyen Z; Gründer C; Marcu-Malina V; Marchant A; Donner C; Plachter B; Vermijlen D; van Baarle D; Kuball J
Leukemia; 2013 Jun; 27(6):1328-38. PubMed ID: 23277330
[TBL] [Abstract][Full Text] [Related]
2. Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.
Litjens NHR; van der Wagen L; Kuball J; Kwekkeboom J
Front Immunol; 2018; 9():389. PubMed ID: 29545802
[TBL] [Abstract][Full Text] [Related]
3. The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation.
Knight A; Madrigal AJ; Grace S; Sivakumaran J; Kottaridis P; Mackinnon S; Travers PJ; Lowdell MW
Blood; 2010 Sep; 116(12):2164-72. PubMed ID: 20576814
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells.
Fisher JP; Yan M; Heuijerjans J; Carter L; Abolhassani A; Frosch J; Wallace R; Flutter B; Capsomidis A; Hubank M; Klein N; Callard R; Gustafsson K; Anderson J
Clin Cancer Res; 2014 Nov; 20(22):5720-32. PubMed ID: 24893631
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.
Varanasi PR; Ogonek J; Luther S; Dammann E; Stadler M; Ganser A; Borchers S; Hambach L; Weissinger EM
PLoS One; 2019; 14(3):e0213739. PubMed ID: 30889204
[TBL] [Abstract][Full Text] [Related]
6. Distinct activities of Vδ1
Liu R; Wu N; Gao H; Liang S; Yue K; Dong T; Dong X; Xu LP; Wang Y; Zhang XH; Liu J; Huang XJ
Immunology; 2022 Nov; 167(3):368-383. PubMed ID: 35795896
[TBL] [Abstract][Full Text] [Related]
7. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen.
Manjappa S; Bhamidipati PK; Stokerl-Goldstein KE; DiPersio JF; Uy GL; Westervelt P; Liu J; Schroeder MA; Vij R; Abboud CN; Fehniger TA; Cashen AF; Pusic I; Jacoby M; Meera SJ; Romee R
Biol Blood Marrow Transplant; 2014 Jan; 20(1):46-52. PubMed ID: 24120526
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.
Alejenef A; Pachnio A; Halawi M; Christmas SE; Moss PA; Khan N
Clin Exp Immunol; 2014 Jun; 176(3):418-28. PubMed ID: 24547915
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
[TBL] [Abstract][Full Text] [Related]
12. CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.
Knight A; Arnouk H; Britt W; Gillespie GY; Cloud GA; Harkins L; Su Y; Lowdell MW; Lamb LS
PLoS One; 2013; 8(8):e68729. PubMed ID: 23950874
[TBL] [Abstract][Full Text] [Related]
13. CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML.
Ito S; Pophali P; CO W; Koklanaris EK; Superata J; Fahle GA; Childs R; Battiwalla M; Barrett AJ
Bone Marrow Transplant; 2013 Oct; 48(10):1313-6. PubMed ID: 23562969
[TBL] [Abstract][Full Text] [Related]
14. Dendritic Cells Are Critical for the Activation and Expansion of Vδ2
Wang X; Liu J; Gao H; Mo XD; Han T; Xu LP; Zhang XH; Huang XJ
Front Immunol; 2018; 9():2528. PubMed ID: 30443256
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus.
Pfirrmann V; Oelsner S; Rettinger E; Huenecke S; Bonig H; Merker M; Wels WS; Cinatl J; Schubert R; Klingebiel T; Bader P
Cytotherapy; 2015 Aug; 17(8):1139-51. PubMed ID: 26072027
[TBL] [Abstract][Full Text] [Related]
16. Elevated granzyme M-expressing lymphocytes during cytomegalovirus latency and reactivation after allogeneic stem cell transplantation.
Bovenschen N; Spijkers SN; Wensink AC; Schellens IM; van Domselaar R; van Baarle D
Clin Immunol; 2014 Jan; 150(1):1-11. PubMed ID: 24316590
[TBL] [Abstract][Full Text] [Related]
17. [Cytomegalovirus reactivation after allogeneic stem cell transplantation reduces the risk of relapse in patients with acute myeloid leukemia].
Takenaka K
Rinsho Ketsueki; 2015 Jul; 56(7):825-30. PubMed ID: 26251145
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.
Feuchtinger T; Opherk K; Bethge WA; Topp MS; Schuster FR; Weissinger EM; Mohty M; Or R; Maschan M; Schumm M; Hamprecht K; Handgretinger R; Lang P; Einsele H
Blood; 2010 Nov; 116(20):4360-7. PubMed ID: 20625005
[TBL] [Abstract][Full Text] [Related]
19. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
Front Immunol; 2020; 11():1804. PubMed ID: 32973756
[TBL] [Abstract][Full Text] [Related]
20. Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B.
Chang KM; Traum D; Park JJ; Ho S; Ojiro K; Wong DK; Wahed AS; Terrault NA; Khalili M; Sterling RK; Janssen HLA; Shuhart MC; Lau DT; Roberts LR; Johnson GS; Kaplan DE; Betts MR; Lee WM; Lok ASF;
PLoS Pathog; 2019 Apr; 15(4):e1007715. PubMed ID: 30998783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]